Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$588,737,534
-$33,362,554 QoQ
Shares Held
10,217,590
-0.4% QoQ
Ownership
0.500%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#29
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $2,307,026,460 across 15 Drug Manufacturers - General names. BMY ranks #1 (25.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
This page
|
10,217,590 | $588,737,534 | |
| 2 | LLY |
ELI LILLY & Co
|
344,960 | $413,755,406 | |
| 3 | PFE |
Pfizer Inc
|
16,584,797 | $399,361,911 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,370,439 | $176,101,411 | |
| 5 | JNJ |
Johnson & Johnson
|
644,520 | $163,688,742 | |
| 6 | AZN |
Astrazeneca PLC
|
558,835 | $105,966,291 | |
| 7 | NVS |
Novartis AG
|
633,523 | $99,285,724 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
716,459 | $90,517,428 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $588,737,534 | 10,217,590 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $622,100,088 | 10,257,215 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $569,267,710 | 10,553,721 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $444,682,166 | 9,859,915 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $181,739,631 | 3,926,110 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $304,530,266 | 4,993,118 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $512,989,358 | 9,069,826 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $513,963,997 | 9,933,591 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $380,091,114 | 9,152,206 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $431,083,651 | 7,949,173 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $206,827,479 | 4,030,939 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $26,211,733 | 451,615 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $23,534,623 | 368,016 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $23,618,906 | 340,772 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $34,957,051 | 485,852 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $36,434,264 | 512,509 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $38,056,403 | 494,239 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $134,175,097 | 1,837,260 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $210,000,535 | 3,368,092 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $183,487,530 | 3,101,023 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $185,993,402 | 2,783,499 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $149,465,262 | 2,367,579 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $122,524,633 | 1,975,248 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $110,126,677 | 1,826,616 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $61,746,526 | 1,050,111 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $56,476,046 | 1,013,205 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||